Psychiatric comorbidities in patients with alopecia areata in Taiwan: A case-control study

British Journal of Dermatology

Volumn 166, Issue 3, 2012, Pages 525-531

  Chu, S Y ^a,b   Chen, Y J ^b,c   Tseng, W C ^d   Lin, M W ^b   Chen, T J ^a   Hwang, C Y ^a,b   Chen, C C ^a,b   Lee, D D ^a,b   Chang, Y T ^a,b   Wang, W J ^a,b   Liu, H N ^a,b,e  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d Taitung Veterans Hospital   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALOPECIA AREATA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; PHOBIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SCHOOL CHILD; TAIWAN;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; MALE; MENTAL DISORDERS; MIDDLE AGED; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84862786421     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10714.x     Document Type: Article

References (53)

1. Safavi K,. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 1992; 128: 702.
2. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-33.
3. Price VH,. Alopecia areata: clinical aspects. J Invest Dermatol 1991; 96: 68S.
4. Mell A, Bale M,. Alopecia areata. Dermatol Clin 1987; 5: 553-60.
5. Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 2011; 65: 949-56.
6. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ,. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42: 434-7. (Pubitemid 36740749)
7. Manolache L, Benea V,. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921-8. (Pubitemid 47103722)
8. Ghanizadeh A,. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol 2008; 47: 1118-20.
9. Arck PC, Slominski A, Theoharides TC, et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 126: 1697-704. (Pubitemid 44086503)
10. Colõn EA, Popkin MK, Callies AL, et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991; 32: 245-51.
11. Koo JY, Shellow WV, Hallman CP, et al. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994; 33: 849-50. (Pubitemid 24374072)
12. Manolache L, Oprea C, Benea V,. Stress and anxiety involved in alopecia areata. Dermatol Psychosom 2003; 4: 112-13.
13. Güleà AT, Tanriverdi N, Dürü C, et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-6. (Pubitemid 38714596)
14. Ricciardi A, Ruberto A, García-Hernández MJ, et al. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment. J Eur Acad Dermatol Venereol 2006; 20: 1000-1.
15. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ, et al. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata. Int J Dermatol 1999; 38: 798-9. (Pubitemid 29515490)
16. Government Information Office. Taiwan Yearbook 2005, Public Health: Health Insurance. Available at: (last accessed 29 November 2011).
17. Cheng TM,. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood) 2003; 22: 61-76.
18. Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009; 137: 1641-8.
19. Chen YJ, Wu CY, Chen TJ, et al. The risk of cancer in patients with psoriasis: a population based cohort study in Taiwan. J Am Acad Dermatol 2010; 65: 84-91.
20. Chen YJ, Wu CY, Lin MW, et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol 2011; 165: 593-9.
21. Kang JH, Tsai MC, Lin CC, et al. Increased risk of Parkinsonism among patients with cirrhosis: a 7-year follow-up study. Liver Int 2011; 31: 685-91.
22. Ho JD, Xirasagar S, Lin HC,. Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. Ophthalmology 2011; 118: 1076-81.
23. Kyriakis KP, Paltatzidou K, Kosma E, et al. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol 2009; 23: 572-3.
24. Furue M, Yamazaki S, Jimbow K, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol 2011; 38: 310-20.
25. Brajac I, Tkalcic M, DragojeviÄ? DM, et al. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol 2003; 30: 871-8. (Pubitemid 38139976)
26. Bashir K, Dar NR, Rao SU,. Depression in adult dermatology outpatients. J Coll Physicians Surg Pak 2010; 20: 811-13.
27. Tucker P,. Bald is beautiful? The psychosocial impact of alopecia areata. J Health Psychol 2009; 14: 142-51.
28. Cordan Yazici A, BaÅ?terzi A, Tot Acar S, et al. Alopecia areata and alexithymia. Turk J Psychiatry 2006; 17: 101-6.
29. Elkin TD, Hilker KA, Drabman RS,. Anxiety and psychosocial concerns in alopecia areata: a case study. Clin Case Stud 2006; 5: 103-11.
30. Liakopoulou MM, Alifieraki TM, Katideniou AM, et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997; 36: 678-84.
31. Reeve EA, Savage TA, Bernstein GA,. Psychiatric diagnoses in children with alopecia areata. J Am Acad Child Adolesc Psychiatry 1996; 35: 1518-22. (Pubitemid 26360938)
32. Allen JP, Porter MR, McFarland FC,. Leaders and followers in adolescent close friendships: susceptibility to peer influence as a predictor of risky behavior, friendship instability, and depression. Dev Psychopathol 2006; 18: 155-72. (Pubitemid 43362220)
33. Gooren EM, van Lier PA, Stegge H, et al. The development of conduct problems and depressive symptoms in early elementary school children: the role of peer rejection. J Clin Child Adolesc Psychol 2011; 40: 245-53.
34. Schmidt S,. Female alopecia: the mediating effect of attachment patterns on changes in subjective health indicators. Br J Dermatol 2003; 148: 1205-11. (Pubitemid 36819221)
35. Hunt N, McHale S,. Reported experiences of persons with alopecia areata. J Loss Trauma 2005; 10: 33-50. (Pubitemid 40046095)
36. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E,. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav (in press).
37. Katsarou-Katsari A, Singh LK, Theoharides TC,. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology 2001; 203: 157-61. (Pubitemid 34701577)
38. Ito N, Kromminga A, Bettermann A, et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005; 19: 1332-4. (Pubitemid 41113740)
39. Slominski A, Wortsman J,. Neuroendocrinology of the skin. Endocr Rev 2000; 21: 457-87.
40. Zhang X, Yu M, Yu W, et al. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009; 129: 1527-38.
41. Theoharides TC, Conti P,. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25: 235-41. (Pubitemid 38501669)
42. Arck PC, Handjiski B, Hagen E, et al. Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001; 15: 2536-8.
43. Peters EM, Handjiski B, Kuhlmei A, et al. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004; 165: 259-71. (Pubitemid 38821833)
44. Blois SM, Tometten M, Kandil J, et al. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J Immunol 2005; 174: 1820-9. (Pubitemid 40223921)
45. Stein DJ, Fineberg NA, Bienvenu OJ, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010; 27: 495-506.
46. Cortese BM, Phan KL,. The role of glutamate in anxiety and related disorders. CNS Spectr 2005; 10: 820-30. (Pubitemid 41531936)
47. Chakrabarty K, Bhattacharyya S, Christopher R, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005; 30: 1735-40. (Pubitemid 43086030)
48. Moghaddam B,. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 1993; 60: 1650-7. (Pubitemid 23127567)
49. Müller N, Schwarz MJ,. Immune system and schizophrenia. Curr Immunol Rev 2010; 6: 213-20.
50. Grace AA,. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology (in press).
51. Müller N, Schwarz MJ,. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl 2007; 72: 269-80.
52. Kubota T, Ishikura T, Jibiki I,. Three cases of alopecia areata induced by zotepine. Acta Neurol (Napoli) 1993; 15: 200-3. (Pubitemid 23247937)
53. Yamamura S, Ohoyama K, Hamaguchi T, et al. Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex. Br J Pharmacol 2009; 157: 656-65.